BILLERICA, Mass., April 13, 2023 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a leading medical device company that features personalized knee and hip replacement products, announced today it ...

Conformis, Inc. (NASDAQ:CFMS) shareholders are doubtless heartened to see the share price bounce 32% in just one week. But will that repair the damage for the weary investors who have owned this stock ...

The FDA sent a warning letter to Conformis, a Billerica, Mass.-based devicemaker specializing in knee implants, citing sterilization issues with the company’s knee replacement systems, according to ...

Designed to enhance operational efficiency for the surgeon, the Conformis Hip System is the most advanced, patient-conforming hip replacement system available BILLERICA, Mass., Nov. 07, 2019 (GLOBE ...

BILLERICA, Mass., Oct. 01, 2019 (GLOBE NEWSWIRE) -- Conformis, Inc. (NASDAQ: CFMS), a medical technology company that uses its proprietary iFit Image-to-Implant technology platform to develop, ...

Product gross profit margin was 38% in the second quarter of 2023, compared to 35% in the same period last year. The product gross margin rate increased year-over-year primarily as a result of higher ...

FARMINGTON, Conn.--(BUSINESS WIRE)-- ORLive.com, BroadcastMed’s premiere surgical broadcasting website, is proud to present a live webinar on the ConforMIS iTotal® G2 Patient-Specific Knee Replacement ...

Please provide your email address to receive an email when new articles are posted on . ConforMIS announced the commercial availability of the iDuo G2, the next generation of its bicompartmental knee ...

Some stocks are best avoided. It hits us in the gut when we see fellow investors suffer a loss. Anyone who held Conformis, Inc. (NASDAQ:CFMS) for five years would be nursing their metaphorical wounds ...

Bob Howe is a senior finance professional with more than 20 years of progressive experience at public medical device companies in roles that encompass financial planning and analysis (FP&A), financial ...